Skip to content

Omar Abdel-Razek, MD

NPI 1912780008ActiveIndividual· Internal Medicine, Interventional Cardiology· Boston, MA

Internal Medicine, Interventional Cardiology (MD) in Boston, Massachusetts, licensed in MA, with an NPI issued in August 2023. Part D covered 25 prescriptions written in 2024, 60% of them generic. Intra-Sana Laboratories reported $115.47 in payments in 2025, mostly food and beverage.

Overview

NPI1912780008
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedAug 14, 2023
Last updated in NPPESAug 14, 2023
Certified by providerAug 14, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)25 · 41 30-day fills
Total drug cost$7,161
Generic share60% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$115.47 · 1 payment from 1 company
  • 2024$1,202 · 13 payments from 5 companies

Top paying companies in 2025

CompanyAmountPayments
Intra-Sana Laboratories$115.471

What the 2025 payments were for

  • Food and Beverage$115.47 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Interventional Cardiology providers in Boston

All Internal Medicine, Interventional Cardiology providers in Massachusetts →